Skip to content
In Stock Tetracycline
Antibiotics

Tetracycline

Tetracycline tablets are an oral product for infections caused by tetracycline-sensitive bacteria. Their use is selected according to susceptibility and may help treat certain respiratory, skin…

Guaranteed quality Original product
Delivery: from 4 days Discreet delivery
24/7 Support Always available
Active ingredient: Tetracycline
Select dosage:
Select pack Package Per tablet Price
€ 0.62 € 112.00
Best value Free Standard Delivery € 0.56 € 224.00 € 203.00 Save 9%
€ 1.65 € 99.00
€ 1.47 € 148.50 € 132.00 Save 11%
€ 1.34 € 198.00 € 161.00 Save 19%
Free Standard Delivery € 1.26 € 297.00 € 226.00 Save 24%
Free Express Delivery € 1.19 € 445.50 € 320.00 Save 28%
Best value Free Express Delivery € 1.16 € 594.00 € 419.00 Save 29%

Free delivery on orders from € 200.00, free express delivery from € 300.00

Secure payment methods:
VISA AMEX JCB DISCOVER

Tetracycline tablets are an oral product for infections caused by tetracycline-sensitive bacteria. Their use is selected according to susceptibility and may help treat certain respiratory, skin, sexually transmitted, and intracellular bacterial infections.

Overview

Tetracycline is a broad-spectrum antibiotic in the tetracyclines class. The product available on this page is an oral tablet of Tetracycline, supplied as a course of tablets. Dosing differs between strengths and between users, so no single amount suits everyone. Its use depends on the infection, bacterial susceptibility, patient age, kidney and liver function, and the prescriber’s treatment plan.

Formulation

The product is identified as Tetracycline Tablets and the available pack contains 28 tablets. Exact composition details beyond the product name are not established here.

Therapeutic indications

Tetracycline may be prescribed for infections caused by tetracycline-sensitive bacteria. Possible clinical uses include selected respiratory tract infections, certain skin infections, some sexually transmitted infections, and particular infections caused by intracellular organisms.

The choice depends on laboratory susceptibility and local resistance patterns. A bacterium may belong to a group historically treated with tetracycline yet still resist the drug. The World Health Organization (WHO) described antimicrobial resistance as a major factor in selecting and monitoring antibiotic treatment [1].

Conditions for which a clinician may consider tetracycline include:

  • Selected infections caused by Chlamydia species.
  • Some rickettsial infections.
  • Certain respiratory infections caused by susceptible organisms.
  • Specific skin and soft-tissue infections.
  • Some infections caused by atypical or intracellular bacteria.
  • Selected ocular infections when an appropriate formulation and route are prescribed.

Tetracycline is not suitable for every bacterial infection. It is not a substitute for treatment directed at bacteria known to resist tetracyclines, and it has no activity against viruses.

Diarrhoea, cough, or a sore throat does not automatically mean that an antibiotic is needed. Tetracycline is useful only when the suspected or confirmed bacteria are likely to respond to it.

Directions for use

  • Route: take Tetracycline tablets orally.
  • Strength: the product is marked 250 mg per tablet.
  • Dose: the prescribed number of 250 mg tablets differs between users and infections; no single dose is suitable for everyone.
  • Frequency: take the tablets at the frequency prescribed for the individual treatment plan.
  • Timing: follow the prescriber’s or regulatory directions for timing in relation to meals and other products.
  • Duration: complete the duration prescribed for the infection.
  • Missed dose: do not double the next dose; follow the prescriber’s or regulatory directions.

When not to use it

Tetracycline is not appropriate for you if any of the following applies unless a specialist has made a specific, documented decision:

  • A previous serious allergic reaction to tetracycline or another tetracycline-class antibiotic.
  • Pregnancy, especially during the second half, unless specialist advice identifies a compelling reason.
  • Breastfeeding when treatment could expose the infant to clinically relevant drug levels.
  • Children under the age limits specified by the prescriber or regulatory product information.
  • A history of severe liver disease where tetracycline could increase hepatic risk.
  • A previous serious reaction involving severe rash, mucosal sores, facial swelling, or breathing difficulty after an antibiotic.

Important interactions include antacids containing aluminium, calcium, or magnesium; iron supplements; zinc products; bismuth-containing preparations; and some mineral-rich products. These substances can bind tetracycline and reduce the amount absorbed.

Warfarin and other medicines affected by changes in intestinal flora may require closer monitoring during antibiotic treatment. Isotretinoin and other systemic retinoids require particular caution because combining them with tetracyclines may increase the risk of raised intracranial pressure. Methoxyflurane is associated with serious renal toxicity when combined with tetracyclines and should not be used in this setting.

Unwanted effects

Common adverse effects include nausea, abdominal discomfort, loose stools, headache, and sensitivity to sunlight. Taking the tablet with enough water and remaining upright can reduce upper gastrointestinal irritation. Severe or persistent diarrhoea can indicate antibiotic-associated colitis and needs prompt medical assessment.

Photosensitivity may cause an exaggerated sunburn-like reaction. This can occur even after ordinary outdoor exposure, especially during bright sunlight. Protective clothing and high-factor sunscreen reduce exposure, though severe blistering or widespread rash requires urgent medical attention.

Other possible reactions include:

  • Rash, itching, facial swelling, or breathing difficulty from hypersensitivity.
  • Inflammation or ulceration of the oesophagus.
  • Changes in oral or vaginal flora, including candidiasis.
  • Headache or visual disturbance associated with raised intracranial pressure.
  • Liver injury, especially in people with additional risk factors or prolonged exposure.
  • Rare blood abnormalities or severe skin reactions.

The patient information for tetracycline-class products identifies special risks in pregnancy, breastfeeding, childhood, and people with significant liver disease. Tetracyclines can bind calcium in developing teeth and bones, potentially causing permanent tooth discolouration or affecting bone growth. Regulatory product information from the EMA describes these restrictions and warnings [2].

How it affects the body

The Tetracycline antibiotic enters susceptible bacterial cells and binds reversibly to the 30S ribosomal subunit. Ribosomes are the structures bacteria use to assemble proteins. By interfering with the attachment of transfer RNA, tetracycline prevents the addition of new amino acids to growing bacterial proteins.

Without adequate protein production, bacteria cannot grow and multiply normally. This explains the bacteriostatic action of tetracycline. The effect is selective because bacterial ribosomes differ from human ribosomes, although adverse effects can still occur through irritation, allergy, altered intestinal flora, or effects on developing tissues.

Resistance can arise through several mechanisms. Bacteria may pump tetracycline out of the cell, protect the ribosome, or reduce drug entry. These mechanisms explain why a previously useful antibiotic may fail against a particular strain.

Tetracycline differs from penicillin at the molecular level. Penicillin interferes with bacterial cell-wall construction, while tetracycline interferes with protein synthesis. Azithromycin acts at the 50S ribosomal subunit, giving it a different target from tetracycline.

Common mistakes

Several everyday errors can reduce treatment success or increase irritation:

  • Taking the tablet with milk, yoghurt, calcium-fortified drinks, or mineral supplements.
  • Swallowing it immediately before lying down.
  • Stopping as soon as fever or pain improves.
  • Saving leftover tablets for a later illness.
  • Taking doses at irregular times.
  • Using oral tetracycline for a viral cold.
  • Staying in strong sunlight without protection.
  • Combining the antibiotic with isotretinoin without medical review.
  • Assuming diarrhoea is always harmless and continuing despite severe or persistent symptoms.

One small detail matters: the tablet should be swallowed with water rather than taken dry. Dry swallowing can leave the tablet in the oesophagus, where local irritation may be painful and prolonged.

Another common mistake is taking tetracycline beside breakfast when the meal contains dairy or added minerals. The issue is absorption, not an allergic reaction, so the person may feel no immediate warning that the dose has been weakened.

Keep a written dosing schedule if the course involves several daily doses. Marking each completed dose helps prevent both missed tablets and accidental double dosing.

Comparison

Tetracyclines share a core mechanism but differ in pharmacokinetic behaviour. Half-life describes how quickly the concentration falls in the body; a longer half-life can allow less frequent administration, depending on the individual product and indication.

Tetracycline-class option Clinical distinction
Tetracycline First-generation oral agent; absorption is strongly affected by minerals and some foods
Doxycycline, minocycline, lymecycline Later derivatives with different dosing schedules, distribution, and tolerability profiles
Omadacycline, eravacycline Newer tetracycline-class antibiotics used in selected serious or resistant infections

Rolitetracycline and demeclocycline are additional tetracycline-class agents with specialised clinical roles. They are not interchangeable with the 250 mg oral tablets described here.

Doxycycline often has more convenient dosing and is used widely for several susceptible infections. Minocycline reaches some tissues effectively but can cause distinctive adverse effects, including dizziness or pigmentation. Lymecycline is used in some dermatological settings. Omadacycline and eravacycline were developed to address selected resistant infections and have different prescribing requirements.

The choice between tetracycline and another tetracycline-class antibiotic is based on the organism, infection site, resistance, renal and hepatic considerations, interactions, and treatment guidelines. A newer derivative is not automatically preferable for every infection.

Tetracycline is a protein-synthesis inhibitor with bacteriostatic activity. Penicillin antibiotics act mainly on bacterial cell-wall synthesis and are often bactericidal against susceptible organisms. Azithromycin is a macrolide that also inhibits protein synthesis, but it binds to a different ribosomal site.

These differences affect antibacterial spectrum, resistance patterns, tissue penetration, adverse effects, and suitability for specific patients. Allergy history also matters. A person with a penicillin allergy may still require separate assessment for tetracycline tolerability because the drug classes are chemically different.

Antibiotic selection should follow the suspected organism and infection site rather than the broad label of “stronger” or “weaker” antibiotic. Using tetracycline when a different class is better suited can delay recovery and promote resistance.

What doctors say

In clinical practice, doctors usually match tetracycline to the suspected organism rather than prescribing it solely because symptoms resemble a previous infection. A good response depends on bacterial susceptibility, sufficient exposure, and taking the full prescribed course at the intended intervals.

Physicians also review medicines that reduce absorption. A patient may report taking every tablet correctly while an iron supplement or antacid has prevented enough tetracycline from entering the bloodstream. This is a common practical reason for treatment failure.

Common questions

Can older adults take Tetracycline?

Older adults may receive tetracycline when the suspected bacteria are susceptible and the prescriber considers kidney, liver, swallowing, and interaction risks. The HPRA product-safety approach in 2023 supports individual assessment rather than an automatic age-based exclusion. Medicines for heartburn, mineral supplements, anticoagulants, and retinoids deserve specific review. Reduced kidney or liver function may affect the choice, monitoring, or duration of treatment. A pharmacist can also help identify timing problems with minerals and other medicines.

Which symptoms mean that Tetracycline should be stopped and assessed urgently?

Facial swelling, wheezing, breathing difficulty, blistering skin, extensive peeling, fainting, or severe weakness may indicate a serious reaction and require urgent medical care. Severe headache with blurred or double vision can signal raised intracranial pressure, a recognised tetracycline-class concern. Profuse or bloody diarrhoea during treatment or after completion needs prompt assessment because antibiotic-associated colitis can be serious. EMA safety information from 2018 identifies severe allergic, neurological, gastrointestinal, and skin reactions as reasons for urgent evaluation.

Can Tetracycline be used during pregnancy or breastfeeding?

Tetracycline is generally avoided during pregnancy when suitable alternatives exist because tetracycline-class drugs can affect developing teeth and bones. The EMA product information from 2018 describes particular concern during later pregnancy and childhood tooth development. Breastfeeding also requires a specific risk assessment because the drug can pass into milk and may expose the infant. The prescriber should know about pregnancy, planned pregnancy, or breastfeeding before treatment begins.

How soon does the effect of Tetracycline become noticeable?

The time to improvement depends on the infection, bacterial susceptibility, infection site, and the person’s immune response. Fever or pain may begin to improve within a few days when the bacteria respond, while skin or ocular findings can take longer. Lack of improvement, deterioration, or new symptoms requires clinical reassessment rather than an automatic increase in dose. WHO antimicrobial-treatment principles published in 2015 support reviewing the diagnosis and susceptibility when the expected response does not occur.

Does Tetracycline cause photosensitivity?

Yes, photosensitivity is a recognised adverse effect of tetracycline and may make skin burn or redden more quickly in sunlight. The reaction can occur during ordinary outdoor exposure, not only after deliberate sunbathing. Protective clothing, shade, and broad-spectrum sunscreen reduce exposure, while blistering or severe redness requires urgent medical advice. The FDA tetracycline labelling information available in 2024 lists photosensitivity among the warnings associated with the class.

What should be checked before starting Tetracycline?

Before treatment, the prescriber should review tetracycline allergy, pregnancy or breastfeeding, age, liver and kidney conditions, and the medicines or supplements being used. Particular attention is needed for antacids, iron, calcium, magnesium, zinc, bismuth products, warfarin, isotretinoin, and systemic retinoids. The likely bacterial cause and local resistance pattern may also influence antibiotic choice. NICE antimicrobial-stewardship guidance from 2015 supports checking diagnosis, interactions, allergies, and treatment duration before an antibiotic is started.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Ampicillin

Active ingredient: Ampicillin
250mg 500mg
From € 80.00
tablets
3.6 (5)

Augmentin

Active ingredient: Amoxicillin, Clavulanic acid
1000mg 375mg 625mg
From € 107.00
tablets
3.7 (3)

Bactrim

Active ingredient: Sulfamethoxazole, Trimethoprim
480mg 960mg
From € 93.00
tablets
4.4 (5)

Cipro

Active ingredient: Ciprofloxacin
250mg 500mg 750mg
From € 101.00
tablets
3.8 (3)

Doxycycline

Active ingredient: Doxycycline
100mg 200mg
From € 77.00
tablets
3.8 (4)

Minocycline

Active ingredient: Minocycline
50mg 100mg
From € 105.00
tablets
3.5 (5)

How the medicines for Antibiotics compare

Pharmaceutical Formulations and Topical Preparations

Tetracycline exists in more than one pharmaceutical formulation. The product described here is an oral tablet. Separate clinical formulations may deliver tetracycline to a local site, such as the eye, and they are not interchangeable with oral tablets.

Formulation Main route and clinical role
Oral tetracycline tablets Systemic treatment of susceptible bacterial infections
Tetracycline Hydrochloride 3% Eye prep Local ophthalmic treatment in selected eye infections
Tetracycline 3% ointment Topical or ophthalmic preparation requiring site-specific directions

The oral tablets reach the bloodstream and may be used when systemic treatment is required. Ophthalmic products are sterile preparations designed for the eye and require different administration instructions. An eye preparation should never be substituted for oral tablets, and oral tablets should not be placed in the eye.

Ophthalmic Uses of Tetracycline 3% Ointment

Tetracycline Hydrochloride 3% Eye prep and Tetracycline 3% ointment represent local preparations used in selected clinical circumstances. Their use depends on the organism, the location of infection, and the diagnosis made by an eye-care professional.

Sterile handling is essential for ophthalmic treatment. The applicator tip must not touch the eye, eyelashes, fingers, or other surfaces because contamination can worsen an eye infection. A topical eye preparation also does not provide the same systemic exposure as an oral tablet.

The tablet form on this page is intended for oral administration. It should not be crushed into an improvised eye preparation or applied to the skin.

Sources

  1. World Health Organization (2015). Global action plan on antimicrobial resistance.
  2. European Medicines Agency (2018). Summary of Product Characteristics (SmPC) — tetracycline.

How Buyers Rate Tetracycline

Based on 3 reviews

Jack, 33 Verified
Rating: 3.5 out of 5

He took the prescribed tetracycline tablets for a bacterial skin infection. Nausea was noticeable during the first few days, and taking each tablet with plenty of water helped. His skin improved during the second week, although sunlight caused quicker redness than usual.

10 Nov 2026
Paul, 28 Verified
Rating: 3.5 out of 5

He completed a course for a respiratory bacterial infection and noticed reduced fever after several days. He had taken the tablets with a mineral supplement at first, then separated them after the interaction was explained. The stomach upset settled, but the dosing timetable was inconvenient.

18 Nov 2026
James, 50 Verified
Rating: 4 out of 5

He stopped treatment early when his symptoms improved and experienced a return of symptoms soon afterwards. A later course was selected after clinical review, with clearer instructions about timing and completion. He reported mild loose stools but no serious reaction.

20 Oct 2026
Get our free app Shop faster and track your orders 3.8 · 404 reviews Install